Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study-Reference-Cited by-同舟云学术

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

Published:2007-06 Issue:6 Volume:6 Page:501-512
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Feldman Howard H,Ferris Steven,Winblad Bengt,Sfikas Nikolaos,Mancione Linda,He Yunsheng,Tekin Sibel,Burns Alistair,Cummings Jeffrey,del Ser Teodoro,Inzitari Domenico,Orgogozo Jean-Marc,Sauer Heinrich,Scheltens Philip,Scarpini Elio,Herrmann Nathan,Farlow Martin,Potkin Steven,Charles H Cecil,Fox Nick C,Lane Roger

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference55 articles.

1. Mild cognitive impairment;Feldman;Am J Geriatr Psychiatry,2005

2. Mild cognitive impairment: clinical characterization and outcome;Petersen;Arch Neurol,1999

3. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials;Grundman;Arch Neurol,2004

4. Current concepts in mild cognitive impairment;Petersen;Arch Neurol,2001

5. Vascular risk factors, incidence of MCI, and rates of progression to dementia;Solfrezzi;Neurology,2004

Cited by 275 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moderation of Amyloid-β Deposition on the Effect of Cholinesterase Inhibitors on Cognition in Mild Cognitive Impairment;Journal of Alzheimer's Disease;2024-08-27

2. Effect of Treatment of the Cholinergic Precursor Choline Alphoscerate in Mild Cognitive Dysfunction: A Randomized Controlled Trial;Medicina;2024-06-01

3. Improvements in performance based measures of functional capacity and cognition after computerized functional skills training in older people with mild cognitive impairment and healthy comparators;Psychiatry Research;2024-04

4. Digital divide is amplifying cognitive disparities among the older population: a community-based cohort study in China;2024-02-27

5. Cognitive Enhancers and Treatments for Alzheimer’s Disease;Tasman’s Psychiatry;2024